[1] Bray F, Ferlay J, Soerjomataram I, et al.Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018,68(6):394-424. [2] Chen W, Zheng R, Baade PD, et al.Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016,66(2):115-132. [3] Kitano S, Iso Y, Moriyama M, et al.Laparoscopy-assisted Billroth I gastrectomy[J]. Surg Laparosc Endosc, 1994,4(2):146-148. [4] Hashizume M, Shimada M, Tomikawa M, et al.Early experiences of endoscopic procedures in general surgery assisted by a computer-enhanced surgical system[J]. Surg Endosc, 2002,16(8):1187-1191. [5] Litynski GS.Profiles in laparoscopy: mouret, dubois, and perissat: the laparoscopic breakthrough in Europe (1987-1988)[J]. JSLS, 1999,3(2):163-167. [6] 胡建昆,张维汉.中国腹腔镜胃癌手术20年术式变迁与发展[J]. 中华普外科手术学杂志(电子版),2021,15(2):129-132. [7] 中华医学会外科学分会腹腔镜与内镜外科学组,中国研究型医院学会机器人与腹腔镜外科专业委员会. 腹腔镜胃癌手术操作指南(2016版)[J]. 中华消化外科杂志,2016,15(9):851-857. [8] 中华医学会外科学分会腹腔镜与内镜外科学组. 腹腔镜胃癌手术操作指南(2007版)[J]. 中华消化外科杂志,2007,6(6):476-480. [9] 黄昌明,陈起跃,刘治羽,等. 中国腹腔镜胃癌手术20年发展、问题与对策[J]. 中华普外科手术学杂志(电子版),2021,15(2):123-128. [10] Xie D, Shen J, Liu L, et al.Complete mesogastric excision for locally advanced gastric cancer: short-term outcomes of a randomized clinical trial[J]. Cell Rep Med,2021,2(3):100217. [11] 胡建昆,杨昆,陈心足,等. 顺向式模块化淋巴结清扫在腹腔镜胃癌手术中的应用[J]. 中华胃肠外科杂志,2017,20(2):200-206. [12] Yu J, Hu J, Huang C, et al.The impact of age and comorbidity on postoperative complications in patients with advanced gastric cancer after laparoscopic D2 gastrectomy: results from the Chinese laparoscropic gastrointestinal surgery study (CLASS) group[J]. Eur J Surg Oncol, 2013,39(10):1144-1149. [13] Hu Y, Huang C, Sun Y, et al.Morbidity and mortality of laparoscopic versus open D2 distal gastrectomy for advanced gastric cancer: a randomized controlled trial[J]. J Clin Oncol, 2016,34(12):1350-1357. [14] Yu J, Huang C, Sun Y, et al.Effect of laparoscopic vs open distal gastrectomy on 3-year disease-free survival in patients with locally advanced gastric cancer: the CLASS-01 randomized clinical trial[J]. JAMA, 2019,321(20):1983-1992. [15] Stell DA, Carter CR, Stewart I, et al.Prospective comparison of laparoscopy, ultrasonography and computed tomography in the staging of gastric cancer[J]. Br J Surg, 1996,83(9):1260-1262. [16] Mirza A, Galloway S.Laparoscopy, computerised tomography and fluorodeoxyglucose positron emission tomography in the management of gastric and gastro-oesophageal junction cancers[J]. Surg Endosc,2016,30(7):2690-2696. [17] Hiki N, Katai H, Mizusawa J, et al.Long-term outcomes of laparoscopy-assisted distal gastrectomy with suprapancreatic nodal dissection for clinical stage I gastric cancer: a multicenter phase II trial (JCOG0703)[J]. Gastric Cancer,2018,21(1):155-161. [18] Lee H J, Hyung W J, Yang H K, et al.Short-term outcomes of a multicenter randomized controlled trial comparing laparoscopic distal gastrectomy with D2 lymphadenectomy to open distal gastrectomy for locally advanced gastric cancer (KLASS-02-RCT)[J]. Ann Surg, 2019,270(6):983-991. [19] 黄昌明,林密. 腹腔镜下脾门淋巴结清扫的技术要点——CLASS-04研究设计的初衷[J]. 中华胃肠外科杂志,2018,21(2):143-147. [20] 黄昌明,曹龙龙. 进展期胃上部癌腹腔镜保脾脾门淋巴结清扫术的难点与争议[J]. 中华消化外科杂志,2017,16(8):787-790. [21] 张俊榕. 346例胃上部癌腹腔镜下保脾的脾门淋巴结清扫术的临床分析[D]. 福建:福建医科大学,2014. [22] 蔡小鹏,张春晓,王舒艺,等.吲哚菁绿示踪剂引导的D2淋巴结清扫在胃癌手术中的应用[J].腹部外科,2020,33(3):208-211. [23] Chen Q Y, Xie J W, Zhong Q, et al.Safety and efficacy of indocyanine green tracer-guided lymph node dissection during laparoscopic radical gastrectomy in patients with gastric cancer: a randomized clinical trial[J]. JAMA Surg, 2020,155(4):300-311. [24] 余佩武. 达芬奇机器人胃癌手术的现状与展望[C].中国医师协会外科医师分会第三届全国微创外科学术会议论文集. 2011:20-22. [25] 2021机器人胃癌切除术后完全腔内消化道重建中国专家共识(全文).2021. [26] Uyama I, Suda K, Nakauchi M, et al.Clinical advantages of robotic gastrectomy for clinical stage I/II gastric cancer: a multi-institutional prospective single-arm study[J]. Gastric Cancer, 2019,22(2):377-385. [27] 徐泽宽,王林俊,李博文.腹腔镜胃癌手术进展及展望[J].中国实用外科杂志,2020,40(2):185-190. [28] 余佩武,罗华星.机器人胃癌外科手术的现状与趋势[J].中国普外基础与临床杂志,2017,24(4):397-399. |